In summary, our work first identified TFCRs in bladder cancer by integrating chromatin accessibility data of ATAC-seq and DNase-seq with TF binding information, and provided a proof of concept for CLIC3 as a regulatory factor of NAT10 protein and of key cellular functions relevant to mRNA ac4C modification. Here, NAT10 is linked to urinary bladder carcinoma.